Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised
Case Medical Research
doi 10.31525/cmr-1866f27
Full Text
Open PDF
Abstract
Available in
full text
Date
July 23, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Atosiban SUN, Atosiban, Premature Birth, Date of Authorisation: 31/07/2013, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Cayston, Aztreonam, Cystic Fibrosis,Respiratory Tract Infections, Date of Authorisation: 21/09/2009, Revision: 17, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): NovoRapid, Insulin Aspart, Diabetes Mellitus, Date of Authorisation: 07/09/1999, Revision: 29, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Mixtard, Insulin Human (rDNA), Diabetes Mellitus, Date of Authorisation: 07/10/2002, Revision: 18, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Tadalafil Mylan, Tadalafil, Erectile Dysfunction, Date of Authorisation: 21/11/2014, Revision: 8, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Silodosin Recordati, Silodosin, Prostatic Hyperplasia, Date of Authorisation: 07/01/2019, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Xgeva, Denosumab, Fractures, Bone,Neoplasm Metastasis, Date of Authorisation: 13/07/2011, Revision: 17, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Olazax, Olanzapine, Schizophrenia,Bipolar Disorder, Date of Authorisation: 11/12/2009, Revision: 10, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Betmiga, Mirabegron, Urinary Bladder, Overactive, Date of Authorisation: 20/12/2012, Revision: 11, Status: Authorised
Case Medical Research
